Abstract
Tropomyosin (Tm) plays a central role in the regulation of muscle contraction and is present in three main isoforms in skeletal and cardiac muscles. In the present work we studied the functional role of α- and βTm on force development by modifying the isoform composition of rabbit psoas skeletal muscle myofibrils and of regulated thin filaments for in vitro motility measurements. Skeletal myofibril regulatory proteins were extracted (78 %) and replaced (98 %) with Tm isoforms as homogenous ααTm or ββTm dimers and the functional effects were measured. Maximal Ca2+ activated force was the same in ααTm versus ββTm myofibrils, but ββTm myofibrils showed a marked slowing of relaxation and an impairment of regulation under resting conditions compared to ααTm and controls. ββTm myofibrils also showed a significantly shorter slack sarcomere length and a marked increase in resting tension. Both these mechanical features were almost completely abolished by 10 mM 2,3-butanedione 2-monoxime, suggesting the presence of a significant degree of Ca2+-independent cross-bridge formation in ββTm myofibrils. Finally, in motility assay experiments in the absence of Ca2+ (pCa 9.0), complete regulation of thin filaments required greater ββTm versus ααTm concentrations, while at full activation (pCa 5.0) no effect was observed on maximal thin filament motility speed. We infer from these observations that high contents of ββTm in skeletal muscle result in partial Ca2+-independent activation of thin filaments at rest, and longer-lasting and less complete tension relaxation following Ca2+ removal.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Tropomyosin (Tm) is a dimeric α chained coiled-coil actin-binding protein which plays a pivotal role in the regulation of striated muscle contraction, acting as the “gatekeeper” of thin filament Ca2+ activation (Gordon et al. 2000; Holmes and Lehman 2008; Lehman et al. 2009; Nevzorov and Levitsky 2011). In the sarcomere, Tm dimers are associated in a head–tail manner and the resulting axial continuity of Tm strands on thin filaments allows cooperative azimuthal movements between switched-on/off positions under the influence of Ca2+ binding to troponin (Tn) and strongly bound cross-bridge formation.
In mammalian striated muscle, there are three major highly homologous Tm isoforms which are product of different genes: αTm (TPM1), βTm (TPM2) and γTm (TPM3) (Perry 2001; Gunning et al. 2008). The expression of isoforms varies with species, muscle type and many other, largely unknown, developmental, hormonal and environmental factors. In mammalian fast skeletal muscles, αTm and βTm are present in variable proportions from 9:1 to 1:1 (Bronson and Schachat 1982; Perry 2001). In the past few years, many studies using solution (Boussouf et al. 2007), cell (Lu et al. 2010) and transgenic (TG) models (Jagatheesan et al. 2009) have investigated the potential functional role of Tm isoforms. This has been mainly in terms of the Ca2+ sensitivity of the contractile apparatus and of cross-bridge access to thin filaments. These studies are complicated by the recent observation that homodimeric and heterodimeric isoforms of Tm are mixed in muscle and their ratios can also affect the overall Tm function in the Ca2+ regulation process (Janco et al. 2013). When α and β isoforms are expressed in an adult skeletal muscle, the preferred form is the heterodimer αβ (Lehrer et al. 1989; Hvidt and Lehrer 1992) with αα homodimers being formed only when the α:β ratio is greater than 1. The formation of ββ homodimer is usually not favoured, probably due to the instability of the resulting Tm molecule at physiological temperature, especially when associated with the adult isoforms of Tn (Lehrer 1975). The physiological significance of the scarce presence of ββTm homodimer in adult skeletal muscle has therefore been questioned. Interestingly, the ββTm isoform is the predominant form in fetal life (Amphlett et al. 1976) and is increased considerably in the presence of mutations of the TPM2 gene associated with skeletal muscle myopathies (e.g., nemaline myopathy or distal arthrogryposis; Nilsson and Tajsharghi 2008). Based on these recent findings, it has been hypothesized that the increase in TPM2 expression and the change in dimeric species of Tm could introduce a critical perturbation of the thin filament Ca2+ regulation process contributing to the pathogenesis of myopathies (Tajsharghi et al. 2012).
The goal of this current study was to investigate the functional consequences of the enrichment of the ββTm content in skeletal muscle myofibrils to get mechanistic insight into the general role of Tm isoforms in regulation. Native Tm from rabbit psoas myofibrils was exchanged with recombinant Tm as ααTm versus ββTm dimers, using the method we previously developed to remove and reconstitute striated muscle myofibrils with exogenous regulatory proteins (Scellini et al. 2010; Janco et al. 2012; Nixon et al. 2013). Replacement of regulatory proteins in single myofibrils offers a number of advantages, as compared to more conventional muscle preparations (She et al. 2000). The smaller diffusion distances allow a more complete and homogeneous exchange of proteins in a much shorter time (Piroddi et al. 2003). Furthermore, fast solution switching methods (Tesi et al. 1999) can be used to abruptly change the concentration of Ca2+ and investigate isometric force development and millisecond-timescale activation and relaxation kinetics. This approach improves the resolution of previous studies performed in vitro (Clemmens et al. 2005) or in skinned fibres from transgenic (TG) mouse models (Pieples et al. 2002; Jagatheesan et al. 2009) and gelsolin treated/reconstituted systems (Fujita et al. 2002, 2004). In addition, in vitro motility assays of actin sliding were performed to determine the regulation state of ααTm versus ββTm-dimer reconstituted thin filaments. The results of this work showed that increased contents of ββTm in thin filaments has no or only small effects on maximal active force development of myofibrils or on the speed of reconstituted thin filament motility. On the other hand, ββTm compromises regulation at pCa 9.0, suggesting that high levels of ββTm in sarcomeres may result in an altered switch-off mechanism and partial Ca2+-independent activation. These results have been previously presented in a preliminary form (Scellini et al. 2011).
Methods
Myofibril isolation and Tm–Tn replacement procedure
Single myofibrils or thin bundles of myofibrils were prepared from rabbit fast skeletal muscle by homogenization of glycerinated psoas muscle, as previously described (Tesi et al. 1999, 2000). Rabbits were killed with pentobarbital (120 mg/kg) administered through the marginal ear vein. All procedures performed were conducted in accordance with the official regulations of the European Community Council on Use of Laboratory Animals (Directive 86/609/EEC) and protocols were approved by the Ethical Committee for Animal Experiments of the University of Florence. All solutions were kept around 0 °C and contained 0.5 mM DTT and a cocktail of protease inhibitors including 10 μM leupeptin, 5 μM pepstatin A, 200 μM phenyl-methylsulphonylfluoride, 10 μM E64 and 500 μM NaN3. Endogenous skeletal Tm and Tn were extracted and replaced with recombinant homodimer αα or ββTm isoforms and rabbit fast skeletal Tn as previously described (Scellini et al. 2010; Siththanandan et al. 2009). Briefly, myofibrils were washed by centrifugation (five–seven times) in a mildly alkaline/low ionic strength solution (2 mM Tris–HCl, pH 8.0) to remove native Tm and Tn. Extracted myofibrils were then washed in 200 mM ionic strength rigor solution (100 mM KCl, 2 mM MgCl2, 1 mM EGTA, 50 mM Tris–HCl, pH 7.0) and reconstituted with exogenous Tm (5 μM) and Tn (2 μM) in a two steps protocol (0 °C, 2 h incubation per step). Tn, extracted and purified from rabbit fast skeletal muscle, was kindly provided by Dr. E. Homsher (UCLA University, Los Angeles, USA). The recombinant homodimer Tms were made as described below. Reconstituted myofibrils were washed and stored in 200 mM ionic strength rigor solution at 4 °C, and used within 3 days. At each stage of the protocol, samples were retained from both supernatant and pellet fractions for electrophoresis assays. The extent of the Tm–Tn extraction and replacement was determined using 15 % SDS-PAGE gels, stained with Coomassie brilliant blue R-250 (Sigma) to reveal the resolved protein bands. To determine the amount and the relative distribution of the various isoform of Tm, Coomassie stained gels were scanned and the gel images were analyzed using UN-SCAN-IT gel 6.0 software (Silk Scientific, Inc., UT, USA). Usually, peaks referring to βTm, TnT and αTm bands were clearly defined and the degree of Tm extraction and reconstitution was assessed determining the ratio of Tm–actin band intensities for each lane. Data obtained from myofibril preparations not permitting accurate gel analysis of replacement were discarded.
Expression and purification of recombinant N-terminal modified ααTm and ββTm
The full-length cDNAs encoded for α and βTm were obtained from mouse heart total RNA by RT-PCR (mouse and rabbit Tm are 100 % identical). These PCR products were further subcloned in reading frame into pET-24a(+) expression vector (Novagen). To restore full function of α and βTm by mimicking the N-terminal acetyl group, an additional nine nucleotides encoding three amino acids (Met-Ala-Ser) were inserted at the 5′-end of each corresponding cDNA by site-directed mutagenesis. These expression constructs were transformed separately into the E. coli strain BL21(DE3) for the production of recombinant Tm proteins. These Tm proteins were purified as previously described (Smillie 1982). The function of the N-terminal modified α or βTm was analyzed by actin binding assays as described before (Monteiro et al. 1994). N-terminal modification of Tm has been shown to mimic the N-terminal acetylation of the native molecule, restoring actin binding, head–tail polymerization and the capacity to inhibit actomyosin ATPase without interfering with functional properties of in vitro (Monteiro et al. 1994; Landis et al. 1999) and myofibril (Siththanandan et al. 2009) systems.
Apparatus for mechanical measurements and rapid solution changes in myofibrils
The system used to record force from single myofibrils and for rapid solution changes has been described earlier (Colomo et al. 1997, 1998; Tesi et al. 2000). Briefly, myofibrils selected for use were mounted horizontally between two glass micro-tools: a calibrated cantilevered force probe and a length-control motor.
The length of attached myofibrils was initially set 10–20 % above slack length (Tesi et al. 1999); initial sarcomere length (sl) was measured by calibrated visualization with a camera and monitor. Isometric force was measured from the deflection of the shadow of the force probe projected on a split photodiode (Cecchi et al. 1993). Myofibrils were activated and relaxed by rapid translation between two continuous streams of relaxing (pCa 9.0) and activating (pCa 4.5) solutions flowing by gravity from a double-barrelled glass pipette placed at right angles to, and within 1 mm of, the preparation. Solution changes after the start of the paired-pipette movement (driven by a stepper-motor-controlled system) occurred with a time-constant of 2–4 ms and were complete within 10 ms (Colomo et al. 1998; Tesi et al. 2000). Experiments were performed at 15 °C in a thermostatically controlled myofibril observation chamber and microscope enclosure.
Maximal isometric force was measured and normalized by cross-sectional area of the preparation (P0); Ca2+ activation rate (k ACT) and the rate of tension redevelopment (k TR) following the imposition of a release–restretch protocol (about 30 % myofibril length; Brenner 1988) were estimated from single-exponential fits as previously described (Tesi et al. 2000). Relaxation rate for the slow phase (slow k REL) was calculated from the slope of the regression line fitted to the tension trace normalized to the entire amplitude of the tension relaxation transient. The relaxation rate for the fast phase (fast k REL) was measured from a single-exponential decay fitted to the data. For fitting, transition from the slow to rapid phase was determined subjectively from individual traces. The duration of the slow phase was measured from tension traces from the onset of solution change at the myofibril to the intercept of the regression line with the fitted exponential. Resting tension development (RT) of myofibrils was measured at pCa 9.0 by imposing 30 % releases of initial length. Analysis of variance was used to compare between myofibril groups after Tm–Tn replacement. Student’s unpaired t tests were used to assess significance.
Data acquisition
Force and length signals were continuously monitored throughout the experiment using commercial software and programs modified for our use (National Instruments®, LabVIEW®). The same signals were also recorded during experimental protocols and later used for data analysis. Data measurements were made directly with a homemade LabVIEW Analysis program converting the analogue signals to numeric values and commercial software (Origin®, SigmaPlot®).
Solutions
All activating and relaxing solutions were calculated as described previously (Tesi et al. 2000) at pH 7.0. The solutions contained: 10 mM total EGTA, 5 mM Mg-ATP, 1 mM free Mg2+, 10 mM MOPS, propionate and sulphate to adjust the final solution to an ionic strength of 200 mM and a monovalent cation concentration of 155 mM. Although continuous solution flow minimizes alterations in the concentration of Mg-ATP and its hydrolysis products in the myofibrillar space, the measurements were made in the presence of creatine phosphate (10 mM) and creatine kinase (200 units/ml) to prevent any ADP gradients. Contaminant [Pi] (around 170 μM in standard solutions) was reduced to less than 5 μM (Pi-free solutions) by a Pi-scavenging enzyme system (purine-nucleoside-phosphorylase with substrate 7-methylguanosine; Tesi et al. 2000, 2002a). Ca–EGTA:EGTA ratio was set to obtain a fully relaxing solution of nominal pCa 9.0 and a maximally activating solution of pCa 4.5 (Brandt et al. 1972). In a few experiments, 10 mM 2,3-butanedione 2-monoxime (BDM) was added to relaxing solution. Nucleoside phosphorylase (‘bacterial’), 7-methylguanosine, ATP, BDM, DTT, leupeptin, E64, phenyl-methylsulphonylfluoride, NaN3 and pepstatin A were purchased from Sigma, creatine phosphate and creatine kinase from Roche Diagnostics.
In vitro motility assay
Rabbit actin and myosin heavy meromyosin (HMM) were purified from rabbit fast skeletal muscle as previously described (Clemmens et al. 2005). Tn subunits and αα or ββTm were recombinant proteins (see above). Unregulated (actin) and regulated (actin + Tm + Tn) motility was measured at 30 °C in flow cells with surfaces containing skeletal HMM. Construction of flow cells and measurement of filament sliding speed and moving filaments were as previously described (Clemmens and Regnier 2004; Clemmens et al. 2005). The concentrations of Tn and Tm used in motility buffer to reconstitute thin filaments that stopped movement varied with the Tm isoform used. Motility buffer (mM): 25 imidazole, 2 Mg-ATP, 1 EGTA, 1 free Mg2+, 50 ionic strength (KCl) pH 7.4. Filament motility data were collected at pCa 9.0 and pCa 5.0 in the presence of antioxidant agents (0.018 mg/ml catalase, 0.1 mg/ml glucose oxidase, 3 mg/ml d-glucose, 40 mM DTT) to minimize photobleaching and photo-oxidative protein damage. Speed or moving fraction versus pCa data were fitted to a four-parameter Hill equation using non-linear regression weighted for SD of individual points (Origin®).
Results
Gel electrophoretic studies of Tm replacement in rabbit psoas myofibrils
Two different reconstituted (Rec) myofibril groups were obtained from control (Ctrl) rabbit psoas myofibrils by Tm–Tn replacement procedure: ααTm (Rec ααTm–Tn) and ββTm (Rec ββTm–Tn) myofibrils. Samples of all myofibril preparations used for mechanical measurements were retained for electrophoretic analysis, as well as fractions of Tm–Tn extracted myofibrils (Ext). Figure 1a shows a representative 15 % Tris–HCl SDS-PAGE gel after Coomassie blue staining of skeletal rabbit psoas myofibril samples kept at each step of the Tm–Tn extraction–reconstitution protocol. For each lane, the amount of protein loaded (4–10 μg) is different due to protein loss during the preparation. Data in the literature regarding the quantitative α and β isoform ratio in fast skeletal muscle are controversial, but it is generally assumed that the α isoform predominates at a ratio of about 4:1 to βTm (Cummins and Perry 1973; Salviati et al. 1982; Perry 2001). The degree of Tm extraction or replacement in each lane was assessed from the intensity profile of scanned gels and determining the ratio of Tm (αTm or βTm) to actin band intensities in the control, extracted and reconstituted samples. After extraction, the (α + β)Tm/actin ratio (lane Ext) is 0.09 ± 0.01 compared to 0.38 ± 0.02 in the controls (lane Ctrl) and 0.35 ± 0.01 and 0.39 ± 0.01 in the reconstituted αα and ββTm myofibrils (lanes Rec), representing about 78 % ± 3 mean value of (α + β)Tm removal and 98 % ± 6 mean value of (α + β)Tm replacement (mean ± s.e.m.; n = 5). Extraction–replacement of fast skeletal Tn was 100 %. Figure 1b shows mean data from five gels regarding the relative amount of α and βTm in control myofibrils and in myofibrils reconstituted with ααTm or ββTm. It can be seen that extraction–replacement protocol strongly affects the α:β Tm isoform ratio, shifting from a prevalence of α over β in control myofibrils (0.84:0.16) to a correspondent prevalence of β over α in ββTm reconstituted myofibrils (0.23:0.77). As expected, enrichment in αTm isoform in ααTm-reconstituted myofibrils is only slight (0.92:0.08). ββTm replacement in rabbit psoas myofibrils ensures the presence of significant amounts of ββTm homodimers in sarcomeres. Potential formation of new αβTm heterodimers by chain exchange during the replacement protocol should be negligible as temperature is maintained around zero throughout the whole procedure (Hvidt and Lehrer 1992).
Impact of the modification of α:β Tm ratio on active force development of myofibrils after extraction–replacement of Tm–Tn
Single or thin bundles of rabbit psoas myofibrils were mounted in the isometric force recording apparatus (15 °C) and Ca2+-activated by fast solution switching from relaxing (pCa 9.0) to fully activating (pCa 4.5) solution. Relaxation from maximal isometric force was then induced by switching myofibrils back to pCa 9.0 solution. Figure 2a shows recordings of a representative activation–relaxation cycle of myofibrils both native (Ctrl, upper trace) and after endogenous Tm–Tn extraction and reconstitution with αα (middle trace) or ββTm (bottom trace). In each contraction, we measured maximal steady-state tension (P0 i.e., force at pCa 4.5 normalized over cross-sectional area) and both the rate of force activation upon Ca2+ switch from pCa 9.0 to pCa 4.5 (k ACT) and the rate of tension redevelopment upon a 30 % rapid release–restretch length manoeuvre imposed on maximal activated steady force (k TR; Brenner 1988). As previously observed, k ACT and k TR of myofibrils activated by rapid solution switching had similar values, indicating that the activation mechanisms including Ca2+ binding to TnC and subsequent thin filament switch-on do not limit the apparent rate of force generation (Colomo et al. 1998)
Relaxation of force, which as previously observed in myofibrils took place in two phases (Tesi et al. 2002b), was characterized by measuring the duration and the rate of the slow phase (slow k REL) and the rate of the fast exponential phase (fast k REL). Mean data are reported in Table 1.
As previously observed (Siththanandan et al. 2009; Scellini et al. 2010), the protocol of extraction–replacement of Tm–Tn led in all myofibril batches to a decrease of maximal isometric tension that here was about 35 %. However, P0 measured after the extraction–replacement protocol was not lower than usually reported for control rabbit psoas myofibril batches (de Tombe et al. 2007; Kreutziger et al. 2008). No difference in P0 was observed between ααTm and ββTm replaced myofibrils (Fig. 2b). In ααTm, k ACT (Fig. 2c) and k TR (Fig. 2d) were also preserved compared to controls. Interestingly, both these rates were significantly decreased in ββTm replaced myofibrils versus control and ααTm replaced myofibrils (for data and significance of the effects see Table 1).
Interestingly, relaxation of force was markedly prolonged in ββTm-reconstituted myofibrils, as shown in Fig. 3a where representative traces of ββTm and ααTm reconstituted myofibrils are shown on an expanded time scale. The comparison of mean relaxation parameters of ββTm versus ααTm replaced myofibrils (Table 1) showed a significant increase in the duration of the slow phase of relaxation (about 20 % P < 0.01) and a significant decrease in fast k REL (about 35 % P < 0.01) with no effect on slow k REL in the presence of an increased sarcomeric content of the ββTm isoform. Replacement with ααTm had a much smaller impact on the rate of fast relaxation, likely due to non-specific “run-down”-like effects of the extraction–replacement treatment, as previously observed (Nixon et al. 2013).
The effects on relaxation kinetics found in ββTm myofibrils are the same as previously observed when control myofibrils were partially relaxed to Ca2+-activation levels just above the contractile threshold (Tesi et al. 2002b) or in the presence of truncated TnI subunits unable to fully inhibit acto-myosin interactions in the absence of Ca2+ (Narolska et al. 2006). This may indicate the presence in ββTm myofibrils of significant levels of Ca2+-independent tension at rest. The finding that the rate of slow phase relaxation (Table 1) was unchanged by Tm isoforms support the hypothesis that slow k REL is primarily determined by the cross-bridge detachment rate at maximal Ca2+ activation and then by the isoform of the myosin heavy chain motor (Poggesi et al. 2005).
Resting properties of myofibrils after extraction–replacement of Tm–Tn
Another consequence of the treatment associated to the extraction–replacement of Tm–Tn (besides the unspecific but significant decrease in P0 and fast k REL) is the decrease in mean sl of myofibrils mounted on the recording apparatus (Table 1; Fig. 1c). This length is adjusted before activation just above slack length, in order to reduce inhomogeneity in sarcomeres and to avoid movements of the myofibril during solution switching. As shown in Table 1 and Fig. 1c, ββTm myofibrils had a large decrease in mean sl that is significant also when compared to ααTm-enriched myofibrils (about 6 %).
The large decrease in mean sl of ββTm myofibrils mounted for force recording at pCa 9.0 suggests that the enrichment in ββTm is associated with an incomplete switched-off state of thin filaments in the absence of Ca2+. To check this hypothesis, mean slack sl of control, ααTm and ββTm enriched myofibrils was measured in free myofibrils in the experimental chamber at pCa 9.0. As shown in Fig. 1c, slack sl of ββTm myofibrils was significantly shorter (1.83 ± 0.04 µm) compared to ααTm (2.28 ± 0.02 µm) and control (2.41 ± 0.03 µm). The addition of 10 mM BDM, an inhibitor of strong cross-bridge formation (McKillop et al. 1994; Regnier et al. 1995) did not significantly affect sl of control or ααTm myofibrils while it had a strong effect on ββTm myofibrils, increasing sl by about 15 % (2.11 ± 0.02; P < 0.05). This result suggests the presence of a significant level of Ca2+-independent activation of force generating acto-myosin interactions in myofibrils replaced with ββTm. This feature is much less evident in the ααTm-replaced myofibrils.
To better investigate passive properties of myofibrils extracted and replaced for Tm–Tn, the steady-state sl–RT relationship was determined in the three myofibril groups by stretching them from slack to increasing sls and measuring the force-drop to zero following the imposition of a large and sudden release (about 30 % l0). sl and RT were measured in conditions minimizing stress relaxation (Belus et al. 2010), i.e., about 10 min after the sl change. Details of the experimental protocol applied to myofibrils are shown in Fig. 4a (bottom trace), together with tension traces for a representative myofibril per each group. The average sl–passive tension relationships of control, ααTm and ββTm (Fig. 4b) are evidence that at rest (pCa 9.0), stiffness is significantly higher in ββTm and the relationship is significantly left-shifted compared to ααTm and non-exchanged controls. Modifications observed in ααTm myofibrils are much smaller and probably due to non-specific effects of the replacement treatment. Interestingly, ββTm reconstituted myofibrils also show an important recovery of force following the release of force to zero (Fig. 4a, third trace from top), suggesting the presence of actively cycling cross-bridges in the absence of Ca2+. As shown in Fig. 4c (and Fig. 4a fourth trace from top), this feature as well as the difference in sl–RT relation between ββTm, ααTm and control myofibrils is almost completely abolished by inhibiting actively cycling cross-bridge formation by 10 mM BDM. The presence of a large and significant amount of Ca2+-independent tension only in ββTm enriched myofibrils compared to ααTm and controls suggests that the finding is not merely due to the replacement method and supports the hypothesis that ββTm is unable to fully inhibit actomyosin interactions in the absence of Ca2+.
ααTm versus ββTm reconstituted thin filament sliding in in vitro motility assays
For motility assays, thin filaments were reconstituted in flow cells on rabbit skeletal HMM coated surfaces, as previously described (Clemmens and Regnier 2004; Clemmens et al. 2005). Motility assay experiments showed that the presence of ββTm or ααTm did not affect reconstituted thin filament motility speed at high Ca2+ concentration. As shown in Fig. 5, the speed (A) and the fraction (B) of moving filaments at pCa 5.0 were indistinguishable in ααTm and ββTm filaments and similarly decreased with decreasing Ca2+ concentration. In agreement with previous observations in gelsolin-treated cardiac fibres (Lu et al. 2010), ββTm-reconstituted thin filaments showed a trend to a higher Ca2+ sensitivity of both the speed and the fraction of moving filaments, but the difference in the present study was not significant. Interestingly, the amount of Tm–Tn needed to reconstitute regulated actin filaments and stop the movement on HMM in resting conditions was different in the presence of ββTm or ααTm (≥2 % moving at pCa 9.0). Achievement of complete regulation of the in vitro systems required greater ββTm (70–75 nM) concentrations compared to αα or native Tm–Tn (30–35 nM). These data further support the hypothesis that high levels of ββTm may result in an altered switch-off mechanism and partial Ca2+-independent activation of reconstituted thin filaments.
Discussion
In the work we present here, we aimed to understand the functional role of the α and βTm isoforms of fast skeletal muscle by enriching the sarcomere of rabbit psoas myofibrils with their homodimeric forms, together with adult fast skeletal muscle Tn. The results of this work further confirmed the advantages and the limitations of the protocol we use to replace the entire Tm–Tn complex of regulatory proteins. As previously observed (Scellini et al. 2010) the mechanical performance of myofibrils was preserved in spite of a trend of the kinetics of force generation and fast force relaxation to slow down and a significant decrease in maximal isometric force. Myofibrils after the replacement procedure may also show a small loss of regulation, as suggested by the decrease of slack sl and its sensitivity to BDM also observed with the ααTm homodimer. These effects can be explained by some “run-down” of the preparation, likely a consequence of the need to use rather un-physiological conditions (pH 8) to extract Tm from its tight association with thin filaments (Siththanandan et al. 2009). For this reason, we carefully designed experiments in order to differentially estimate the effects of the various Tm replacements, above the non-specific effect of the treatment. A further limitation of our method is that we could not fully control the Tm compositions of thin filaments, although we did achieve a significant modification of Tm isoform content in skeletal sarcomeres, from a prevalence of α over β (80:20) in control rabbit psoas muscle to an almost correspondent prevalence of β over α (77:23) in ββTm reconstituted myofibrils. Unfortunately, methods that permit a full control of thin filament composition by gelsolin treatment (Fujita et al. 1996, 2002, 2004; Lu et al. 2010) only work in the myocardium and leave the study of the functional role of Tm in skeletal muscle an unexplored field, at least by direct manipulation of sarcomere protein composition. Specific aim of this work was the investigation of the functional role of βTm, the product of the TPM2 gene that is usually present in low percentages in adult skeletal muscle and almost always in the heterodimeric αβ form (Bronson and Schachat 1982; Schachat et al. 1985; Briggs et al. 1990; for a review see Perry 2001). Interestingly, an increase in the presence of the ββTm is also observed in adult human skeletal muscles in the presence of TPM2 mutations associated with skeletal muscle myopathies (Tajsharghi et al. 2012). As the functional role of ββTm in skeletal muscle is unknown, in case of TPM2 mutations associated with skeletal myopathies, it is impossible to dissect functional effects due to Tm mutations themselves or due to the increased presence of ββTm in sarcomere. For this reason, we focused our study on the effects of ββTm per se, considering this as a test case for the interpretation of the many studies that over the last 20 years tried to understand the possible differential role of Tm isoforms (mainly βTm) in striated muscle. Most of these studies were performed in cardiac muscle, using gelsolin-treated fibres or TG animals. Lu et al. (2010), using bovine cardiac fibres with cardiac Tn and ββTm reconstituted thin-filaments, reported no change in mechanical properties of contraction at saturated Ca2+ with a significant (0.2 pCa units) increase in Ca2+ sensitivity and a significant decrease of cooperativity. The preservation of maximal force and the increase in Ca2+ sensitivity was also observed in adult TG murine models overexpressing βTm in the heart at organ (Muthuchamy et al. 1995), trabeculae (Palmiter et al. 1996) or single cell (Wolska et al. 1999) levels. The presence of βTm in TG mouse hearts (NTG hearts are pure αTm) was accompanied by a decrease in the kinetics of force relaxation (Muthuchamy et al. 1995; Wolska et al. 1999) and in some cases also by a decrease of the speed of contraction and force development (Wolska et al. 1999; for a review of mouse model investigation of Tm function see Jagatheesan et al. 2010).
Results from the present study also show that in skeletal muscle myofibrils at full Ca2+ activation, the increase in sarcomeric ββTm content up to about 80 % had no or minor effect on maximal isometric force. The kinetics of force development and redevelopment were essentially preserved in ββTm myofibrils compared to ααTm-enriched or control myofibrils, being the small but significant reduction of k ACT and k TR observed in ββTm myofibrils likely explained by the presence of significant amount of Ca2+-independent tension. A similar decrease in k ACT and k TR, with no change in P0 and with prolongation of relaxation phase was previously observed in both cardiac (Narolska et al. 2006) and skeletal (Belus et al. 2007) myofibrils in the presence of truncated forms of TnI unable to completely switch-off thin filaments in the absence of Ca2+. Regarding the functional role of Tm isoforms in skeletal muscle, the only information available comes from solution studies of Tm isoforms in the assembly with actin filaments and interacting with myosin heads (Boussouf et al. 2007; for a review see Janco et al. 2012). These studies observed no significant difference in Ca2+ sensitivity of skeletal myosin S1 binding to thin filaments reconstituted with skeletal Tn and pure ααTm or ββTm, a condition that simulates the fast skeletal myofibrils of our experiments. Interestingly, Boussouf et al. observed that in the presence of cardiac Tn, the Ca2+ sensitivity of thin filaments reconstituted with ββTm was greater (about 0.2 pCa units) compared with thin filaments reconstituted with ααTm, as previously observed in gelsolin treated cardiac fibres (Lu et al. 2010) and TG mouse overexpressing ββTm (for a discussion of this differential effect see Boussouf et al. 2007). Our in vitro motility data and preliminary experiments in rabbit psoas myofibrils replaced with the two Tm isoforms (Scellini et al. 2011) are in agreement with solution studies of skeletal systems, reporting no difference in Ca2+ sensitivity with just a trend to an increase in ββTm myofibrils.
A novel finding of the present work is that in skeletal muscle, ββTm compromises thin filament regulation in resting conditions (pCa 9.0), as suggested by the decrease in resting slack sl, left shift of the sl–passive tension relation and by the prolongation of relaxation (increase in the duration of the slow phase and decrease in the rate of the fast phase). All these effects observed in ββTm-enriched myofibrils suggest an altered switch-off mechanism and partial Ca2+-independent activation of thin filaments. The specific effect of BDM on resting sl and resting length–tension relation strongly suggests the presence of a significant amount of actively cycling cross-bridges in the absence of Ca2+ in ββTm myofibrils. Interestingly, the same behaviour was previously observed in skeletal myofibrils showing partial loss of regulation associated with truncated forms of TnI (Belus et al. 2007) or engineered Tms with reduced flexibility (Scellini et al. 2012). As to the prolongation of the slow phase of relaxation and the decrease in fast k REL observed in ββTm myofibrils, they could be due to a reduction of Ca2+ dissociation from thin filament and then extended cross-bridges life time (Nixon et al. 2013) and/or to a modification in the equilibria of Ca2+ dependent regulation processes of muscle contraction (Scellini et al. 2012). We favour this second explanation because when an engineered TnC with reduced Ca2+ dissociation rate (k off) was exchanged in skeletal myofibrils, it led to a prolongation of the slow phase of relaxation without the decrease of fast k REL that was observed here in ββTm myofibrils (Kreutziger et al. 2008). On the other hand, a similar increase in the duration of the slow relaxation phase and decrease in fast k REL was observed in control rabbit psoas myofibrils partially relaxed to Ca2+-activation levels just above the contractile threshold (Tesi et al. 2002a, b) or, in both skeletal and cardiac myofibrils, in the presence of truncated cTnI unable to fully inhibit acto-myosin interactions in the absence of Ca2+ (Narolska et al. 2006; Belus et al. 2007). The partial loss of regulation in resting conditions observed here with ββTm cannot be explained by Tm reintroduction failure. The absence of some Tm molecules in the expected position on actin filaments would lead to discontinuous formation of cross-bridge leading to irregular modification of sl along the myofibril and eventually to the disruption of the fragile lattice structure. In addition very small (less than 2 %) reintroduction failure is expected from the gel analysis shown in Fig. 1.
On the other hand, murine TG models overexpressing βTm showed modifications of the regulation state in relaxing conditions and of the relaxation kinetics similar to what observed here in myofibrils after ββTm replacement (Muthuchamy et al. 1995; Jagatheesan et al. 2010).
Within the widely accepted three-state theory of muscle regulation (McKillop and Geeves 1993), the effects observed here in the presence of high levels of ββTm in skeletal sarcomeres could be explained by a reduction of the fraction of “Blocked” states in absence of Ca2+ (about 50 % in skeletal muscle—Maytum et al. 2003) and the formation of a “Myosin-induced open state” (Lehrer 2011). This hypothesis is supported by structural studies of the location of Tm on F-actin filaments free of Tn (Lehman et al. 2000) reporting that in the presence of β isoform the molecule lays preferentially on the inner domain of actin in a closed-like “C-state” position away from the blocked state, which is occupied by the ααTm form. Many factors associated with Tm isoforms may change the fractional occupancy of the myosin induced open state (which is low in control conditions). For example, it is possible that the packing of Tm on actin filaments could be altered by the presence of homodimeric ββTm mixed with ααTm and/or that the head–tail overlap of αα with ββTm disrupts the TnT binding site, leading to the partial loss of regulation observed here (see discussion in Lu et al. 2010). This situation may simulate the physiological state of muscles overexpressing TPM2. Interestingly, engineered Tm variants with reduced molecular flexibility induce functional alterations when replaced in myofibrils, which are very similar to what observed here in the presence of increased content of ββTm in sarcomeres (Scellini et al. 2012). The possibility of a difference in molecular flexibility between ααTm and ββTm forms is supported by spectroscopic measurements of rotational dynamics of Tm on actin surface which was decreased in the presence of 20 % β-chains compared to pure αα (Chandy et al. 1999). In conclusion, our study using skeletal muscle myofibrils replaced with Tm isoforms in the homodimeric form suggest that the overexpression of the TPM2 gene product could lead to an incomplete switch-off of thin filaments in the absence of Ca2+. This effect could be further amplified or damped by the matching of the Tn subunit isoforms, by the presence of mutations in the Tm molecule (as those associated with myopathies and cardiomyopathies) or, as recently suggested, by the isoforms of the myosin motor itself (Kopylova et al. 2013).
References
Amphlett GW, Syska H, Perry SV (1976) The polymorphic forms of tropomyosin and troponin I in developing rabbit skeletal muscle. FEBS Lett 63:22–26
Belus A, Narolska NA, Piroddi N, Scellini B, Deppermann S, Jaquet K, Foster DB, van Eyk J, van der Velden J, Tesi C, Stienen GJ, Poggesi C (2007) Human C-terminal truncated cardiac troponin I exchanged into rabbit psoas myofibrils is unable to fully inhibit acto-myosin interaction in the absence of Ca2+. Biophys J 92:629a
Belus A, Piroddi N, Ferrantini C, Tesi C, Cazorla O, Toniolo L, Drost M, Mearini G, Carrier L, Rossi A, Mugelli A, Cerbai E, van der Velden J, Poggesi C (2010) Effects of chronic atrial fibrillation on active and passive force generation in human atrial myofibrils. Circ Res 107:144–152
Boussouf SE, Maytum R, Jaquet K, Geeves MA (2007) Role of tropomyosin isoforms in the calcium sensitivity of striated muscle thin filaments. J Muscle Res Cell Motil 28:49–58
Brandt PW, Reuben JP, Grundfest H (1972) Regulation of tension in the skinned crayfish muscle fiber. II. Role of calcium. J Gen Physiol 59:305–317
Brenner B (1988) Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction. Proc Natl Acad Sci USA 85:3265–3269
Briggs MM, McGinnis HD, Schachat F (1990) Transitions from fetal to fast troponin T isoforms are coordinated with changes in tropomyosin and alpha-actinin isoforms in developing rabbit skeletal muscle. Dev Biol 140:253–260
Bronson DD, Schachat FH (1982) Heterogeneity of contractile proteins. Differences in tropomyosin in fast, mixed and slow skeletal muscles of the rabbit. J Biol Chem 257:3937–3944
Cecchi G, Colomo F, Poggesi C, Tesi C (1993) A force transducer and a length-ramp generator for mechanical investigations of frog-heart myocytes. Pflug Arch 423:113–120
Chandy IK, Lo JC, Ludescher RD (1999) Differential mobility of skeletal and cardiac tropomyosin on the surface of F-actin. Biochemistry 38:9286–9294
Clemmens EW, Regnier M (2004) Skeletal regulatory proteins enhance thin filament sliding speed and force by skeletal HMM. J Muscle Res Cell Motil 25:515–525
Clemmens EW, Entezari M, Martyn DA, Regnier M (2005) Different effects of cardiac versus skeletal muscle regulatory proteins on in vitro measures of actin filament speed and force. J Physiol 566:737–746
Colomo F, Piroddi N, Poggesi C, te Kronnie G, Tesi C (1997) Active and passive forces of isolated myofibrils from cardiac and fast skeletal muscle of the frog. J Physiol 500:535–548
Colomo F, Nencini S, Piroddi N, Poggesi C, Tesi C (1998) Calcium dependence of the apparent rate of force generation in single myofibrils from striated muscle activated by rapid solution changes. Adv Exp Med Biol 453:373–382
Cummins P, Perry SV (1973) The subunits and biological activity of polymorphic forms of tropomyosin. Biochem J 133:765–777
De Tombe PP, Belus A, Piroddi N, Scellini B, Walker JS, Martin AF, Tesi C, Poggesi C (2007) Myofilament calcium sensitivity does not affect cross-bridge activation–relaxation kinetics. Am J Physiol Regul Integr Comp Physiol 292:R1129–R1136
Fujita H, Yasuda K, Niitsu S, Funatsu T, Ishiwata S (1996) Structural and functional reconstitution of thin filaments in the contractile apparatus of cardiac muscle. Biophys J 71:2307–2318
Fujita H, Sasaki D, Ishiwata S, Kawai M (2002) Elementary steps of the cross-bridge cycle in bovine myocardium with and without regulatory proteins. Biophys J 82:915–928
Fujita H, Lu X, Suzuki M, Ishiwata S, Kawai M (2004) The effect of tropomyosin on force and elementary steps of the cross-bridge cycle in reconstituted bovine myocardium. J Physiol 556:637–649
Gordon AM, Homsher E, Regnier M (2000) Regulation of contraction in striated muscle. Physiol Rev 80:853–924
Gunning P, O’Neill G, Hardeman E (2008) Tropomyosin-based regulation of the actin cytoskeleton in time and space. Physiol Rev 88:1–35
Holmes KC, Lehman W (2008) Gestalt-binding of tropomyosin to actin filaments. J Muscle Res Cell Motil 29:213–219
Hvidt S, Lehrer SS (1992) Thermally induced chain exchange of frog alpha beta-tropomyosin. Biophys Chem 45:51–59
Jagatheesan G, Rajan S, Schulz EM, Ahmed RP, Petrashevskaya N, Schwartz A, Boivin GP, Arteaga GM, Wang T, Wang YG, Ashraf M, Liggett SB, Lorenz J, Solaro RJ, Wieczorek DF (2009) An internal domain of beta-tropomyosin increases myofilament Ca(2+) sensitivity. Am J Physiol Heart Circ Physiol 297:H181–H190
Jagatheesan G, Rajan S, Wieczorek DF (2010) Investigations into tropomyosin function using mouse models. J Mol Cell Cardiol 48:893–898
Janco M, Kalyva A, Scellini B, Piroddi N, Tesi C, Poggesi C, Geeves MA (2012) α-Tropomyosin with a D175N or E180G mutation in only one chain differs from tropomyosin with mutations in both chains. Biochemistry 51:9880–9890
Janco M, Suphamungmee W, Li X, Lehman W, Lehrer SS, Geeves MA (2013) Polymorphism in tropomyosin structure and function. J Muscle Res Cell Motil 34:177–187
Kopylova GV, Shchepkin DV, Nikitina LV (2013) Study of regulatory effect of tropomyosin on actin–myosin interaction in skeletal muscle by in vitro motility assay. Biochemistry (Mosc) 78:260–266
Kreutziger KL, Piroddi N, Scellini B, Tesi C, Poggesi C, Regnier M (2008) Thin filament Ca2+ binding properties and regulatory unit interactions alter kinetics of tension development and relaxation in rabbit skeletal muscle. J Physiol 586:3683–3700
Landis C, Back N, Homsher E, Tobacman LS (1999) Effect of phosphorylation on the interaction and functional properties of rabbit striated muscle αα-tropomyosin. J Biol Chem 274:31279–31285
Lehman W, Hatch V, Korman V, Rosol M, Thomas L, Maytum R, Geeves MA, Van Eyk JE, Tobacman LS, Craig R (2000) Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments. J Mol Biol 302:593–606
Lehman W, Galińska-Rakoczy A, Hatch V, Tobacman LS, Craig R (2009) Structural basis for the activation of muscle contraction by troponin and tropomyosin. J Mol Biol 388:673–681
Lehrer SS (1975) Intramolecular crosslinking of tropomyosin via disulfide bond formation: evidence for chain register. Proc Natl Acad Sci USA 72:3377–3381
Lehrer SS (2011) The 3-state model of muscle regulation revisited: is a fourth state involved? J Muscle Res Cell Motil 32:203–208
Lehrer SS, Qian YD, Hvidt S (1989) Assembly of the native heterodimer of Rana esculenta tropomyosin by chain exchange. Science 246:926–928
Lu X, Heeley DH, Smillie LB, Kawai M (2010) The role of tropomyosin isoforms and phosphorylation in force generation in thin-filament reconstituted bovine cardiac muscle fibres. J Muscle Res Cell Motil 31:93–109
Maytum R, Westerdorf B, Jaquet K, Geeves MA (2003) Differential regulation of the actomyosin interaction by skeletal and cardiac troponin isoforms. J Biol Chem 278:6696–6701
McKillop DF, Geeves MA (1993) Regulation of the interaction between actin and myosin subfragment 1: evidence for three states of the thin filament. Biophys J 65:693–701
McKillop DF, Fortune NS, Ranatunga KW, Geeves MA (1994) The influence of 2,3-butanedione 2-monoxime (BDM) on the interaction between actin and myosin in solution and in skinned muscle fibres. J Muscle Res Cell Motil 15:309–318
Monteiro PB, Lataro RC, Ferro JA, Reinach Fde C (1994) Functional alpha-tropomyosin produced in Escherichia coli. A dipeptide extension can substitute the amino-terminal acetyl group. J Biol Chem 269:10461–10466
Muthuchamy M, Grupp IL, Grupp G, O’Toole BA, Kier AB, Boivin GP, Neumann J, Wieczorek DF (1995) Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart. J Biol Chem 270:30593–30603
Narolska NA, Piroddi N, Belus A, Boontje NM, Scellini B, Deppermann S, Zaremba R, Musters RJ, dos Remedios C, Jaquet K, Foster DB, Murphy AM, van Eyk JE, Tesi C, Poggesi C, van der Velden J, Stienen GJ (2006) Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle. Circ Res 99:1012–1020
Nevzorov IA, Levitsky DI (2011) Tropomyosin: double helix from the protein world. Biochemistry (Mosc) 76:1507–1527
Nilsson J, Tajsharghi H (2008) Beta-tropomyosin mutations alter tropomyosin isoform composition. Eur J Neurol 15:573–578
Nixon BR, Liu B, Scellini B, Tesi C, Piroddi N, Ogut O, Solaro RJ, Ziolo MT, Janssen PM, Davis JP, Poggesi C, Biesiadecki BJ (2013) Tropomyosin Ser-283 pseudo-phosphorylation slows myofibril relaxation. Arch Biochem Biophys 535:30–38
Palmiter KA, Kitada Y, Muthuchamy M, Wieczorek DF, Solaro RJ (1996) Exchange of beta- for alpha-tropomyosin in hearts of transgenic mice induces changes in thin filament response to Ca2+, strong cross-bridge binding, and protein phosphorylation. J Biol Chem 271:11611–11614
Perry SV (2001) Vertebrate tropomyosin: distribution, properties and function. J Muscle Res Cell Motil 22:5–49
Pieples K, Arteaga G, Solaro RJ, Grupp I, Lorenz JN, Boivin GP, Jagatheesan G, Labitzke E, De Tombe PP, Konhilas JP, Irving TC, Wieczorek DF (2002) Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca(2+) activation. Am J Physiol Heart Circ Physiol 283:H1344–H1353
Piroddi N, Tesi C, Pellegrino MA, Tobacman LS, Homsher E, Poggesi C (2003) Contractile effects of the exchange of cardiac troponin for fast skeletal troponin in rabbit psoas single myofibrils. J Physiol 552:917–931
Poggesi C, Tesi C, Stehle R (2005) Sarcomeric determinants of striated muscle relaxation kinetics. Pflug Arch 449:505–517
Regnier M, Morris C, Homsher E (1995) Regulation of the cross-bridge transition from a weakly to strongly bound state in skinned rabbit muscle fibers. Am J Physiol 269:C1532–C1539
Salviati G, Betto R, Danieli Betto D (1982) Polymorphism of myofibrillar proteins of rabbit skeletal-muscle fibres. An electrophoretic study of single fibres. Biochem J 207:261–272
Scellini B, Piroddi N, Poggesi C, Tesi C (2010) Extraction and replacement of the tropomyosin–troponin complex in isolated myofibrils. Adv Exp Med Biol 682:163–174
Scellini B, Lundy S, Piroddi N, Flint G, Tu A, Luo Z, Gordon AM, Regnier M, Poggesi C, Tesi C (2011) Role of tropomyosin (Tm) isoforms in skeletal muscle thin filament regulation. J Muscle Res Cell Motil 32:112–113
Scellini B, Ferrara C, Piroddi N, Sumida J, Poggesi C, Lehrer SS, Tesi C (2012) Tropomyosin flexibility modulates Ca2+ sensitivity of thin filament and affects tension relaxation in skeletal muscle myofibrils after troponin–tropomyosin removal and reconstitution. J Muscle Res Cell Motil 33:246
Schachat FH, Bronson DD, McDonald OB (1985) Heterogeneity of contractile proteins. A continuum of troponin–tropomyosin expression in mammalian skeletal muscle. J Biol Chem 260:1108–1113
She M, Trimble D, Yu LC, Chalovich JM (2000) Factors contributing to troponin exchange in myofibrils and in solution. J Muscle Res Cell Motil 21:737–745
Siththanandan VB, Tobacman LS, Van Gorder N, Homsher E (2009) Mechanical and kinetic effects of shortened tropomyosin reconstituted into myofibrils. Pflug Arch 458:761–776
Smillie LB (1982) Methods in enzymology 85:234–241. Academic Press, New York
Tajsharghi H, Ohlsson M, Palm L, Oldfors A (2012) Myopathies associated with β-tropomyosin mutations. Neuromuscul Disord 22:923–933
Tesi C, Colomo F, Nencini S, Piroddi N, Poggesi C (1999) Modulation by substrate concentration of maximal shortening velocity and isometric force in single myofibrils from frog and rabbit fast skeletal muscle. J Physiol 516:847–853
Tesi C, Colomo F, Nencini S, Piroddi N, Poggesi C (2000) The effect of inorganic phosphate on force generation in single myofibrils from rabbit skeletal muscle. Biophys J 78:3081–3092
Tesi C, Colomo F, Piroddi N, Poggesi C (2002a) Characterization of the cross-bridge force-generating step using inorganic phosphate and BDM in myofibrils from rabbit skeletal muscles. J Physiol 541:187–199
Tesi C, Piroddi N, Colomo F, Poggesi C (2002b) Relaxation kinetics following sudden Ca(2+) reduction in single myofibrils from skeletal muscle. Biophys J 83:2142–2151
Wolska BM, Keller RS, Evans CC, Palmiter KA, Phillips RM, Muthuchamy M, Oehlenschlager J, Wieczorek DF, de Tombe PP, Solaro RJ (1999) Correlation between myofilament response to Ca2+ and altered dynamics of contraction and relaxation in transgenic cardiac cells that express beta-tropomyosin. Circ Res 84:745–751
Acknowledgments
This work was supported by 7th Framework Programs of the European Union (STREP Project “BIG-HEART”, Grant Agreement 241577) by Telethon-Italy (GGP07133), by Ministero Italiano dell’Università e Ricerca scientifica MIUR (PRIN 2010R8JK2X_002) and NIH R01 HL11197 (MR). The authors gratefully acknowledge Sig. Alessandro Aiazzi for skillfull technical advice and design and Dr. Michael Geeves and Dr. Sam Lehrer for helpful discussions.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scellini, B., Piroddi, N., Flint, G.V. et al. Impact of tropomyosin isoform composition on fast skeletal muscle thin filament regulation and force development. J Muscle Res Cell Motil 36, 11–23 (2015). https://doi.org/10.1007/s10974-014-9394-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10974-014-9394-9